Go west, FDA

Whereas the FDA's first two centers for regulatory sciences were focused on modernizing methods for evaluating drugs and devices and on building bridges with local academia, the agency now is looking at early drug development.

To do so, the FDA partnered with Stanford University and the University of California, San Francisco (UCSF) to create a new center focused on quantitative pharmacology that will give it a foothold on the West Coast...